Target intelligence / Profile preview

Phenazine biosynthesis-like domain-containing protein (PBLD)

Target
PBLD
Molecular classification
Enzyme (putative; family relationship to bacterial phenazine biosynthetic enzymes, but human function unclear[2][1]), Other (structurally belongs to the phenazine biosynthesis-like protein family[2])
01

Overview

Phenazine biosynthesis-like domain-containing protein (PBLD) is a human protein encoded by the PBLD gene on chromosome 10. It is the only known mammalian representative of the phenazine biosynthesis-like family, which is structurally related to bacterial enzymes involved in secondary metabolite synthesis. However, the exact molecular and catalytic function of PBLD in humans remains unknown. It is widely expressed across tissues and has been associated with various disease processes, including cancer (as a tumor suppressor), metabolic disorders, and responses to viral infection and folate deficiency. Current knowledge suggests it has protein binding activity and may regulate signaling pathways influencing epithelial maintenance and cellular stress responses[1][2][3][9]. No drugs are known to target PBLD directly, and its enzyme activity in humans is not well defined.

Other names
MAWBPMAWDBPFLJ14767MAWD-binding proteinHEL-S-306epididymis secretory protein Li 306epididymis secretory sperm binding protein
02

Biological functions

Maintenance of gastrointestinal epithelium[1]Negative regulation of transforming growth factor beta receptor signaling pathway[1]May act as a tumor suppressor[3]Putative involvement in cellular metabolism and amino acid modification (by analogy to family proteins[2])
03

Disease associations

Cancer (downregulated in hepatocellular carcinoma; linked to breast cancer progression[1][9][2][3])Insulin resistance[2]Folate deficiency response[2]Viral hepatitis B and C response[2]Hypertension/hypotension response[2]Retinal arterial tortuosity[1]
04

Biomarkers

Altered expression in hepatocellular carcinoma (downregulated)[9]Elevated in disease states such as insulin resistance, folate deficiency, hepatitis, hypotension[2]

Beyond the preview

Go deeper on Phenazine biosynthesis-like domain-containing protein (PBLD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenazine biosynthesis-like domain-containing protein (PBLD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call